Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 355Neoplasms 252Carcinoma, Non-Small-Cell Lung 199Colorectal Neoplasms 181Lung Neoplasms 151Prostatic Neoplasms 150Carcinoma, Hepatocellular 127Leukemia, Myeloid, Acute 96Pancreatic Neoplasms 86Multiple Myeloma 82Neoplasm Metastasis 73Recurrence 72Uterine Cervical Neoplasms 68Rectal Neoplasms 68Ovarian Neoplasms 65Stomach Neoplasms 64Triple Negative Breast Neoplasms 59Squamous Cell Carcinoma of Head and Neck 57Brain Neoplasms 56Head and Neck Neoplasms 55Glioblastoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Small Cell Lung Carcinoma 48Melanoma 45Endometrial Neoplasms 43Disease 43Esophageal Neoplasms 42Hematologic Neoplasms 41Glioma 41Colonic Neoplasms 41

Interventions

Taxes 1Oxaliplatin 1Leucovorin 1Irinotecan 1Gemcitabine 1Fluorouracil 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Cancer Resectable × 1 year × Clear all
NCT07155629 2025-09-04

LEFT-PANC

Helsinki University Central Hospital

Phase 3 Not yet recruiting
381 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡